Daniel Tassé
Tracked across 3 events · 18 articles · First seen May 12, 2026 · Last active Jun 05, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Business
DBV Technologies, a late-stage biopharmaceutical company, announced that its CEO, Daniel Tassé, will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference on June 9, 2026, in Miami, FL. The…
Impact: Daniel Tassé, CEO of DBV Technologies, will participate in a fireside chat at the conference, representing the company and its strategic direction.
Jun 05, 2026 · 6 articles
Tech
DBV Technologies announced the screening of the first participant in its THRIVE Phase 2 clinical study for the VIASKIN Peanut Patch. This study evaluates the efficacy and safety of the patch in infants aged 6…
Impact: Daniel Tassé, CEO of DBV Technologies, expressed optimism about the THRIVE study's potential to transform lives and validate early intervention for peanut allergy.
Jun 02, 2026 · 6 articles
80
Daniel Tassé will participateDBV Technologies to attend...
NEWSDESK
Track Daniel Tassé live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard